Dyfyniad APA

Foldi, J., Silber, A., Reisenbichler, E., Singh, K., Fischbach, N., Persico, J., . . . Pusztai, L. (2021). Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer. NPJ Breast Cancer.

Dyfyniad Arddull Chicago

Foldi, Julia, et al. "Neoadjuvant Durvalumab Plus Weekly Nab-paclitaxel and Dose-dense Doxorubicin/cyclophosphamide in Triple-negative Breast Cancer." NPJ Breast Cancer 2021.

Dyfyniad MLA

Foldi, Julia, et al. "Neoadjuvant Durvalumab Plus Weekly Nab-paclitaxel and Dose-dense Doxorubicin/cyclophosphamide in Triple-negative Breast Cancer." NPJ Breast Cancer 2021.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.